{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:06:07Z","timestamp":1773252367610,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T00:00:00Z","timestamp":1429833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/npp.2015.120","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T11:03:00Z","timestamp":1429873380000},"page":"2715-2726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders"],"prefix":"10.1038","volume":"40","author":[{"given":"Jared W","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E","family":"Kamenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-6164","authenticated-orcid":false,"given":"Kerin K","family":"Higa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A","family":"Light","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,24]]},"reference":[{"key":"BFnpp2015120_CR1","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1038\/npp.2012.155","volume":"37","author":"C Achat-Mendes","year":"2012","unstructured":"Achat-Mendes C, Nic Dhonnchadha BA, Platt DM, Kantak KM, Spealman RD (2012). Glycine transporter-1 inhibition preceding extinction training inhibits reacquisition of cocaine seeking. Neuropsychopharmacology 37: 2837\u20132845.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015120_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnins.2013.00103","volume":"7","author":"DT Acheson","year":"2013","unstructured":"Acheson DT, Twamley EW, Young JW (2013). Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development. Front Neurosci 7: 103.","journal-title":"Front Neurosci"},{"key":"BFnpp2015120_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3758\/s13415-013-0204-4","volume":"14","author":"N Amitai","year":"2013","unstructured":"Amitai N, Young JW, Higa K, Sharp RF, Geyer MA, Powell SB (2013). Isolation rearing effects on probabilistic learning and cognitive flexibility in rats. Cogn Affect Behav Neurosci 14: 388\u2013406.","journal-title":"Cogn Affect Behav Neurosci"},{"key":"BFnpp2015120_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1037\/a0028667","volume":"26","author":"K Armstrong","year":"2012","unstructured":"Armstrong K, Williams LE, Heckers S (2012). Revised associative inference paradigm confirms relational memory impairment in schizophrenia. Neuropsychology 26: 451\u2013458.","journal-title":"Neuropsychology"},{"key":"BFnpp2015120_CR5","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/npp.2009.233","volume":"35","author":"A Bari","year":"2010","unstructured":"Bari A, Theobald DE, Caprioli D, Mar AC, Aidoo-Micah A, Dalley JW et al (2010). Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology 35: 1290\u20131301.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015120_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.euroneuro.2013.10.001","volume":"24","author":"SA Barnes","year":"2014","unstructured":"Barnes SA, Der-Avakian A, Markou A (2014). Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia. Eur Neuropsychopharmacol 24: 744\u2013758.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2015120_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00213-003-1751-0","volume":"174","author":"JC Bensadoun","year":"2004","unstructured":"Bensadoun JC, Brooks SP, Dunnett SB (2004). Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine. Psychopharmacology (Berl) 174: 396\u2013405.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2015120_CR8","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1176\/appi.ajp.2007.06081358","volume":"164","author":"RW Buchanan","year":"2007","unstructured":"Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP et al (2007). The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry 164: 1593\u20131602.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2015120_CR9","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1038\/npp.2014.4","volume":"39","author":"SA Castner","year":"2014","unstructured":"Castner SA, Murthy NV, Ridler K, Herdon H, Roberts BM, Weinzimmer DP et al (2014). Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates. Neuropsychopharmacology 39: 2742\u20132749.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015120_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/wps.20087","volume":"13","author":"BN Cuthbert","year":"2014","unstructured":"Cuthbert BN (2014). The RDoC framework: facilitating transition from ICD\/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 13: 28\u201335.","journal-title":"World Psychiatry"},{"key":"BFnpp2015120_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.schres.2013.01.003","volume":"144","author":"E Demeter","year":"2013","unstructured":"Demeter E, Guthrie SK, Taylor SF, Sarter M, Lustig C (2013). Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: evidence from a translational Sustained Attention Task. Schizophr Res 144: 136\u2013141.","journal-title":"Schizophr Res"},{"key":"BFnpp2015120_CR12","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1038\/tp.2013.74","volume":"3","author":"A Der-Avakian","year":"2013","unstructured":"Der-Avakian A, D'Souza MS, Pizzagalli DA, Markou A (2013). Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research. Transl Psychiatry 3: e297.","journal-title":"Transl Psychiatry"},{"key":"BFnpp2015120_CR13","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.biopsych.2009.10.020","volume":"67","author":"EC Dowd","year":"2010","unstructured":"Dowd EC, Barch DM (2010). Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators. Biol Psychiatry 67: 902\u2013911.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2015120_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00008877-200006000-00006","volume":"11","author":"BA Ellenbroek","year":"2000","unstructured":"Ellenbroek BA, Cools AR (2000). Animal models for the negative symptoms of schizophrenia. Behav Pharmacol 11: 223\u2013233.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2015120_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0023-9690(73)90023-4","volume":"4","author":"PW Frey","year":"1973","unstructured":"Frey PW, Colliver JA (1973). Sensitivity and responsibility measures for discrimination learning. Learn Motiv 4: 327\u2013342.","journal-title":"Learn Motiv"},{"key":"BFnpp2015120_CR16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.jpsychires.2013.07.019","volume":"47","author":"M Fuste","year":"2013","unstructured":"Fuste M, Pinacho R, Melendez-Perez I, Villalmanzo N, Villalta-Gil V, Haro JM et al (2013). Reduced expression of SP1 and SP4 transcription factors in peripheral blood mononuclear cells in first-episode psychosis. J Psychiatr Res 47: 1608\u20131614.","journal-title":"J Psychiatr Res"},{"key":"BFnpp2015120_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/schbul\/sbn068","volume":"34","author":"JM Gold","year":"2008","unstructured":"Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA (2008). Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull 34: 835\u2013847.","journal-title":"Schizophr Bull"},{"key":"BFnpp2015120_CR18","volume-title":"Signal Detection Theory and Psychophysics","author":"DM Green","year":"1966","unstructured":"Green DM, Swets JA (1966) Signal Detection Theory and Psychophysics. Wiley & Sons: New York: New York."},{"key":"BFnpp2015120_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","volume":"60","author":"K Hashimoto","year":"2003","unstructured":"Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N et al (2003). Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60: 572\u2013576.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2015120_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","volume":"56","author":"U Heresco-Levy","year":"1999","unstructured":"Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M (1999). Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 56: 29\u201336.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2015120_CR21","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/npp.2010.9","volume":"35","author":"WM Howe","year":"2010","unstructured":"Howe WM, Ji J, Parikh V, Williams S, Mocaer E, Trocme-Thibierge C et al (2010). Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology 35: 1391\u20131401.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015120_CR22","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1001\/jama.2010.555","volume":"303","author":"TR Insel","year":"2010","unstructured":"Insel TR, Wang PS (2010). Rethinking mental illness. JAMA 303: 1970\u20131971.","journal-title":"JAMA"},{"key":"BFnpp2015120_CR23","doi-asserted-by":"crossref","unstructured":"Javitt DC (2012). Glycine transport inhibitors in the treatment of schizophrenia. Handb Exp Pharmacol 367\u2013399.","DOI":"10.1007\/978-3-642-25758-2_12"},{"key":"BFnpp2015120_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1017\/S1461145701002590","volume":"4","author":"DC Javitt","year":"2001","unstructured":"Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M et al (2001). Adjunctive high-dose glycine in the treatment of schizophrenia. Int J Neuropsychopharmacol 4: 385\u2013391.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2015120_CR25","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1176\/ajp.151.8.1234","volume":"151","author":"DC Javitt","year":"1994","unstructured":"Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP (1994). Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 151: 1234\u20131236.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2015120_CR26","doi-asserted-by":"publisher","first-page":"e66327","DOI":"10.1371\/journal.pone.0066327","volume":"8","author":"B Ji","year":"2013","unstructured":"Ji B, Wang X, Pinto-Duarte A, Kim M, Caldwell S, Young JW et al (2013). Prolonged ketamine effects in hypomorphic mice: mimicking phenotypes of schizophrenia. PLoS One 8: e66327.","journal-title":"PLoS One"},{"key":"BFnpp2015120_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1369-1600.2011.00367.x","volume":"17","author":"HH Lido","year":"2012","unstructured":"Lido HH, Marston H, Ericson M, Soderpalm B (2012). The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598. Addict Biol 17: 897\u2013907.","journal-title":"Addict Biol"},{"key":"BFnpp2015120_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","volume":"81","author":"ED Luby","year":"1959","unstructured":"Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959). Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry 81: 363\u2013369.","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"BFnpp2015120_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/schbul\/sbr065","volume":"38","author":"SJ Luck","year":"2011","unstructured":"Luck SJ, Ford JM, Sarter M, Lustig C (2011). CNTRICS final biomarker selection: control of Attention. Schizophr Bull 38: 53\u201361.","journal-title":"Schizophr Bull"},{"key":"BFnpp2015120_CR30","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.neubiorev.2012.05.009","volume":"37","author":"C Lustig","year":"2013","unstructured":"Lustig C, Kozak R, Sarter M, Young JW, Robbins TW (2013). CNTRICS final animal model task selection: control of attention. Neurosci Biobehav Rev 37: 2099\u20132110.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2015120_CR31","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.neubiorev.2013.08.007","volume":"37","author":"A Markou","year":"2013","unstructured":"Markou A, Salamone JD, Bussey TJ, Mar AC, Brunner D, Gilmour G et al (2013). Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. Neurosci Biobehav Rev 37: 2149\u20132165.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2015120_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0926-6410(96)00012-2","volume":"3","author":"HM Marston","year":"1996","unstructured":"Marston HM (1996). Analysis of cognitive function in animals, the value of SDT. Brain Res Cogn Brain Res 3: 269\u2013277.","journal-title":"Brain Res Cogn Brain Res"},{"key":"BFnpp2015120_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/BF02246109","volume":"117","author":"J McGaughy","year":"1995","unstructured":"McGaughy J, Sarter M (1995). Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology (Berl) 117: 340\u2013357.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2015120_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.neuron.2012.05.004","volume":"74","author":"FJ McMahon","year":"2012","unstructured":"McMahon FJ, Insel TR (2012). Pharmacogenomics and personalized medicine in neuropsychiatry. Neuron 74: 773\u2013776.","journal-title":"Neuron"},{"key":"BFnpp2015120_CR35","volume-title":"A Primer of Signal Detection Theory","author":"D McNicol","year":"1972","unstructured":"McNicol D (1972) A Primer of Signal Detection Theory. George Allen & Unwin: London: London."},{"key":"BFnpp2015120_CR36","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","volume":"66","author":"W Perry","year":"2009","unstructured":"Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ et al (2009). A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 66: 1072\u20131080.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2015120_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1399-5618.2011.00941.x","volume":"13","author":"R Pinacho","year":"2011","unstructured":"Pinacho R, Villalmanzo N, Lalonde J, Haro JM, Meana JJ, Gill G et al (2011). The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium. Bipolar Disord 13: 474\u2013485.","journal-title":"Bipolar Disord"},{"key":"BFnpp2015120_CR38","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.bbamcr.2014.02.008","volume":"1843","author":"A Priya","year":"2014","unstructured":"Priya A, Johar K, Nair B, Wong-Riley MT (2014). Specificity protein 4 (Sp4) regulates the transcription of AMPA receptor subunit GluA2 (Gria2). Biochim Biophys Acta 1843: 1196\u20131206.","journal-title":"Biochim Biophys Acta"},{"key":"BFnpp2015120_CR39","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.bbamcr.2013.07.002","volume":"1833","author":"A Priya","year":"2013","unstructured":"Priya A, Johar K, Wong-Riley MT (2013). Specificity protein 4 functionally regulates the transcription of NMDA receptor subunits GluN1, GluN2A, and GluN2B. Biochim Biophys Acta 1833: 2745\u20132756.","journal-title":"Biochim Biophys Acta"},{"key":"BFnpp2015120_CR40","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.neuroimage.2011.08.055","volume":"59","author":"JD Ragland","year":"2012","unstructured":"Ragland JD, Blumenfeld RS, Ramsay IS, Yonelinas A, Yoon J, Solomon M et al (2012a). Neural correlates of relational and item-specific encoding during working and long-term memory in schizophrenia. Neuroimage 59: 1719\u20131726.","journal-title":"Neuroimage"},{"key":"BFnpp2015120_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/schbul\/sbr168","volume":"38","author":"JD Ragland","year":"2012","unstructured":"Ragland JD, Cohen NJ, Cools R, Frank MJ, Hannula DE, Ranganath C (2012b). CNTRICS imaging biomarkers final task selection: Long-term memory and reinforcement learning. Schizophr Bull 38: 62\u201372.","journal-title":"Schizophr Bull"},{"key":"BFnpp2015120_CR42","doi-asserted-by":"publisher","first-page":"9882","DOI":"10.1073\/pnas.0701946104","volume":"104","author":"B Ramos","year":"2007","unstructured":"Ramos B, Gaudilliere B, Bonni A, Gill G (2007). Transcription factor Sp4 regulates dendritic patterning during cerebellar maturation. Proc Natl Acad Sci U S A 104: 9882\u20139887.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFnpp2015120_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/arclin\/17.3.235","volume":"17","author":"CA Riccio","year":"2002","unstructured":"Riccio CA, Reynolds CR, Lowe P, Moore JJ (2002). The continuous performance test: a window on the neural substrates for attention? Arch Clin Neuropsychol 17: 235\u2013272.","journal-title":"Arch Clin Neuropsychol"},{"key":"BFnpp2015120_CR44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/BF00216022","volume":"91","author":"A Sahgal","year":"1987","unstructured":"Sahgal A (1987). Some limitations of indices derived from signal detection theory: evaluation of an alternative index for measuring bias in memory tasks. Psychopharmacology (Berl) 91: 517\u2013520.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2015120_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/mp.2009.124","volume":"16","author":"J Shi","year":"2011","unstructured":"Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA et al (2011). Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 16: 193\u2013201.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2015120_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/dneu.22212","volume":"75","author":"X Sun","year":"2014","unstructured":"Sun X, Pinacho R, Saia G, Punko D, Meana JJ, Ramos B et al (2014). Transcription factor Sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning. Dev Neurobiol 75: 93\u2013108.","journal-title":"Dev Neurobiol"},{"key":"BFnpp2015120_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1006\/dbio.1996.0134","volume":"176","author":"DM Supp","year":"1996","unstructured":"Supp DM, Witte DP, Branford WW, Smith EP, Potter SS (1996). Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability, and male fertility. Dev Biol 176: 284\u2013299.","journal-title":"Dev Biol"},{"key":"BFnpp2015120_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1042\/BST0380445","volume":"38","author":"GW Tam","year":"2010","unstructured":"Tam GW, van de Lagemaat LN, Redon R, Strathdee KE, Croning MD, Malloy MP et al (2010). Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem Soc Trans 38: 445\u2013451.","journal-title":"Biochem Soc Trans"},{"key":"BFnpp2015120_CR49","first-page":"40","volume":"261C","author":"J van Enkhuizen","year":"2013","unstructured":"van Enkhuizen J, Acheson D, Risbrough V, Drummond S, Geyer MA, Young JW (2013). Sleep deprivation impairs performance in the 5-choice continuous performance test: Similarities between humans and mice. Behav Brain Res 261C: 40\u201348.","journal-title":"Behav Brain Res"},{"key":"BFnpp2015120_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1037\/a0020882","volume":"25","author":"JA Waltz","year":"2011","unstructured":"Waltz JA, Frank MJ, Wiecki TV, Gold JM (2011). Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling. Neuropsychology 25: 86\u201397.","journal-title":"Neuropsychology"},{"key":"BFnpp2015120_CR51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.schres.2007.03.010","volume":"93","author":"JA Waltz","year":"2007","unstructured":"Waltz JA, Gold JM (2007). Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr Res 93: 296\u2013303.","journal-title":"Schizophr Res"},{"key":"BFnpp2015120_CR52","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/schbul\/sbu026","volume":"40","author":"DH Wolf","year":"2014","unstructured":"Wolf DH, Satterthwaite TD, Kantrowitz JJ, Katchmar N, Vandekar L, Elliott MA et al (2014). Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull 40: 1328\u20131337.","journal-title":"Schizophr Bull"},{"key":"BFnpp2015120_CR53","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1111\/j.1471-4159.2010.07073.x","volume":"115","author":"TX Xu","year":"2010","unstructured":"Xu TX, Ma Q, Spealman RD, Yao WD (2010). Amphetamine modulation of long-term potentiation in the prefrontal cortex: dose dependency, monoaminergic contributions, and paradoxical rescue in hyperdopaminergic mutant. J Neurochem 115: 1643\u20131654.","journal-title":"J Neurochem"},{"key":"BFnpp2015120_CR54","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0269881114555252","volume":"29","author":"J Young","year":"2015","unstructured":"Young J, Geyer M (2015). Developing treatments for cognitive deficits in schizophrenia: the challenge of translation. J Psychopharmacol 29: 178\u2013196.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2015120_CR55","doi-asserted-by":"publisher","first-page":"S361","DOI":"10.1016\/S0920-9964(12)71054-X","volume":"136","author":"J Young","year":"2012","unstructured":"Young J, Kamenski M, Geyer M (2012). Delayed 'eureka' of alpha 7 nicotinic acetylcholine receptor knockout mice in a probabilistic reversal learning paradigm. Schizophr Res 136: S361.","journal-title":"Schizophr Res"},{"key":"BFnpp2015120_CR56","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.biopsych.2009.12.015","volume":"67","author":"JW Young","year":"2010","unstructured":"Young JW, Geyer MA (2010). Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors? Biol Psychiatry 67: 784\u2013787.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2015120_CR57","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1038\/tp.2013.82","volume":"3","author":"JW Young","year":"2013","unstructured":"Young JW, Geyer MA, Rissling AJ, Sharp RF, Eyler LT, Asgaard GL et al (2013a). Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice. Transl Psychiatry 3: e324.","journal-title":"Transl Psychiatry"},{"key":"BFnpp2015120_CR58","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.neubiorev.2012.10.002","volume":"37","author":"JW Young","year":"2013","unstructured":"Young JW, Jentsch JD, Bussey TJ, Wallace TL, Hutcheson DM (2013b). Consideration of species differences in developing novel molecules as cognition enhancers. Neurosci Biobehav Rev 37: 2181\u20132193.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2015120_CR59","doi-asserted-by":"publisher","first-page":"e4227","DOI":"10.1371\/journal.pone.0004227","volume":"4","author":"JW Young","year":"2009","unstructured":"Young JW, Light GA, Marston HM, Sharp R, Geyer MA (2009). The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. PLoS One 4: e4227.","journal-title":"PLoS One"},{"key":"BFnpp2015120_CR60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbr.2012.11.028","volume":"240","author":"JW Young","year":"2013","unstructured":"Young JW, Meves JM, Geyer MA (2013c). Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test. Behav Brain Res 240: 119\u2013133.","journal-title":"Behav Brain Res"},{"key":"BFnpp2015120_CR61","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1601-183X.2011.00711.x","volume":"10","author":"JW Young","year":"2011","unstructured":"Young JW, Meves JM, Tarantino IS, Caldwell S, Geyer MA (2011). Delayed procedural learning in alpha7-nicotinic acetylcholine receptor knockout mice. Genes Brain Behav 10: 720\u2013733.","journal-title":"Genes Brain Behav"},{"key":"BFnpp2015120_CR62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/7854_2010_62","volume-title":"Behavioral Neurobiology of Schiozphrenia and Its Treatment","author":"JW Young","year":"2010","unstructured":"Young JW, Zhou X, Geyer MA (2010) Animal models of schizophrenia. In: Swerdlow NR (ed) Behavioral Neurobiology of Schiozphrenia and Its Treatment. Springer: Berlin: Berlin pp. 391\u2013433."},{"key":"BFnpp2015120_CR63","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.mp.4001621","volume":"10","author":"X Zhou","year":"2005","unstructured":"Zhou X, Long JM, Geyer MA, Masliah E, Kelsoe JR, Wynshaw-Boris A et al (2005). Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization. Mol Psychiatry 10: 393\u2013406.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2015120_CR64","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1093\/hmg\/ddq298","volume":"19","author":"X Zhou","year":"2010","unstructured":"Zhou X, Nie Z, Roberts A, Zhang D, Sebat J, Malhotra D et al (2010). Reduced NMDAR1 expression in the Sp4 hypomorphic mouse may contribute to endophenotypes of human psychiatric disorders. Hum Mol Genet 19: 3797\u20133805.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2015120_CR65","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1601-183X.2006.00256.x","volume":"6","author":"X Zhou","year":"2007","unstructured":"Zhou X, Qyang Y, Kelsoe JR, Masliah E, Geyer MA (2007). Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice. Genes Brain Behav 6: 269\u2013276.","journal-title":"Genes Brain Behav"},{"key":"BFnpp2015120_CR66","doi-asserted-by":"publisher","first-page":"e5196","DOI":"10.1371\/journal.pone.0005196","volume":"4","author":"X Zhou","year":"2009","unstructured":"Zhou X, Tang W, Greenwood TA, Guo S, He L, Geyer MA et al (2009). Transcription factor SP4 is a susceptibility gene for bipolar disorder. PLoS One 4: e5196.","journal-title":"PLoS One"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2015120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2015120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2015120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:51:44Z","timestamp":1684453904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2015120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,24]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFnpp2015120"],"URL":"https:\/\/doi.org\/10.1038\/npp.2015.120","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,24]]},"assertion":[{"value":"14 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}